• Profile
Close

Radiotherapy alone or with chemotherapy in the management of carcinoma of the supraglottic larynx: A 25-year community hospital experience

American Journal of Clinical Oncology Aug 29, 2018

Rao AR, et al. - In this retrospective review of 46 patients with localized carcinoma of the supraglottic larynx treated from January 1987 through January 2012 at a community hospital, researchers assessed the outcomes for patients treated with definitive radiotherapy for carcinoma of the supraglottic larynx vs the literature. At 5 years, the estimated local-regional control rate was 70%, ultimate LRC was 82%, laryngeal preservation was 65%, overall survival (OS) was 53%, disease-free survival was 75% and cause-specific survival rate was 76%. Compared to literature, comparable outcomes were reported in this study. A benefit for disease control or OS was neither seen with hyperfractionation nor with chemotherapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay